SCHEMBL17667131

SCHEMBL17667131

CC1(C)c2ccc(Br)cc2-c2c1c1ccccc1n2-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.40
▸ IL1R1 P14778 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ MDM2 Q00987 2/20 0.35
▸ MAPT P10636 4/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GAA P10253 3/20 0.35
▸ MGAM O43451 2/20 0.35
▸ SI P14410 2/20 0.35
▸ MGAM2 Q2M2H8 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17667126 0.94 PDE4B (0.42) PDE4BIL1R1MDM2MAPTL3MBTL1
SCHEMBL17667139 0.90 PDE4B (0.37) PDE4BIL1R1HDAC4MDM2MAPT
SCHEMBL17667135 0.85 L3MBTL1 (0.46) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17689978 0.85 IL1R1 (0.37) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17667111 0.85 PDE4B (0.33) PDE4BMAPTMEN1HTTKMT2A
SCHEMBL17667102 0.84 L3MBTL1 (0.43) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17667107 0.83 IL1R1 (0.34) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17667122 0.82 IL1R1 (0.34) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17667141 0.81 IL1R1 (0.37) IL1R1HDAC4MAPTL3MBTL1MEN1
SCHEMBL17710607 0.81 IL1R1 (0.37) IL1R1HDAC4MAPTL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3006426-B1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2019-01-09 — — EP disclosed
US-9985216-B2 Indenoindole derivative and organic electroluminescent element HODOGAYA CHEMICAL CO., LTD. (JP) 2018-05-29 — — US disclosed
US-20160126468-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2016-05-05 — — US disclosed
EP-3006426-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2016-04-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126468-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDO2, SLCO2B1, IDO1 PDE4B 4126/4885IL1R1 2572/4885HDAC4 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback